December 2021 FDA Recall Clobetasol Propionate by Taro Pharmaceuticals U.s.a., Inc.
D-0375-2022 - Microbial Contamination of Non-Sterile Products

This Class I drug recall was voluntarily initiated by Taro Pharmaceuticals U.s.a., Inc. on December 15, 2021 for the product Clobetasol Propionate. The FDA reported the reason for recall as microbial contamination of non-sterile products. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0375-2022

Reason for Recall
Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria
Initiated
12-15-2021
Reported
01-19-2022
Quantity
96 tubes

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Taro Pharmaceuticals U.S.A., Inc.
Two distributors in UT and LA who could have further distributed to the retail level nationwide in the USA.
Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC 51672-1259-3

Batch or Lot Expiration Information

Lot# AC13786, exp. date DEC 2022